CAMBRIDGE, Mass., and MOUNTAIN VIEW, Calif., – Livongo Health is teaming up with Voluntis to offer its Livongo for Diabetes program with Voluntis’ Insulia, an FDA-cleared medical device and app that provides basal insulin dose recommendations for people with Type 2 diabetes. “By integrating with Insulia, we can give members with Type 2 diabetes additional insight and tips for medication optimization—making managing diabetes easier,” said Dr. Jennifer Schneider, chief medical officer of Livongo, in a statement. The goal of the program is to create an expanded solution that improves medication adherence and optimization by offering better information personalized to Livongo members. The program includes a cellular-enabled blood glucose meter, unlimited checking supplies for members and 24/7 coaching based on actual real-time blood sugar and patient information. Voluntis will launch Insulia throughout the United States in 2017.
You are here: / / Livongo, Voluntis team to offer diabetes management program